Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Concert Pharma (CNCE)
NASDAQ:CNCE
Holding CNCE?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 18, 2022 | Peter Barton Hutt Director | xxxxxxxxxxxxx | $21553 |
| Jun 06, 2022 | Christi Van Heek Director | xxxxxxxxxxxxx | $49999 |
| Jun 06, 2022 | Richard Aldrich Director | xxxxxxxxxxxxx | $999999 |
| Jun 06, 2022 | Thomas Auchincloss Director | xxxxxxxxxxxxx | $28500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2022 | xxxxxxxxxxxxx | $490519 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Concert Pharma (CNCE)?
Currently, no data Available
What percentage of Concert Pharma (CNCE) stock is held by institutional investors?
Currently, no data Available
What percentage of Concert Pharma (CNCE) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Concert Pharma (CNCE)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.